©The Author(s) 2025.
World J Radiol. Oct 28, 2025; 17(10): 108804
Published online Oct 28, 2025. doi: 10.4329/wjr.v17.i10.108804
Published online Oct 28, 2025. doi: 10.4329/wjr.v17.i10.108804
Figure 2 Residual hepatocellular carcinoma after trans-arterial chemoembolization in a 72-year-old man with hepatitis C virus-related hepatic cirrhosis.
A: On unenhanced computed tomography obtained one month after trans-arterial chemoembolization the residual tumor (dotted arrow) shows no Lipiodol retention and the necrotic tumor (arrow) shows homogeneous Lipiodol retention; B: On hepatic arterial phase the residual tumor shows enhancement and the necrotic tumor shows no enhancement; C: On delayed phase the residual tumor shows wash-out.
- Citation: Agnello F, Taibbi A, Galia M, Orlando A, Gagliardo C, Bartolotta TV. Hepatocellular carcinoma treatment response: Imaging findings and criteria. World J Radiol 2025; 17(10): 108804
- URL: https://www.wjgnet.com/1949-8470/full/v17/i10/108804.htm
- DOI: https://dx.doi.org/10.4329/wjr.v17.i10.108804